Truist Financial’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,537
| Closed | -$204K | – | 2620 |
|
|
2022
Q2 | $204K | Sell |
3,537
-135
| -4% | -$7.79K | ﹤0.01% | 2425 |
|
|
2022
Q1 | $228K | Sell |
3,672
-93
| -2% | -$5.78K | ﹤0.01% | 2454 |
|
|
2021
Q4 | $268K | Sell |
3,765
-532
| -12% | -$37.9K | ﹤0.01% | 2394 |
|
|
2021
Q3 | $322K | Hold |
4,297
| – | – | ﹤0.01% | 2266 |
|
|
2021
Q2 | $332K | Hold |
4,297
| – | – | ﹤0.01% | 2282 |
|
|
2021
Q1 | $317K | Hold |
4,297
| – | – | ﹤0.01% | 2228 |
|
|
2020
Q4 | $302K | Sell |
4,297
-198
| -4% | -$13.9K | ﹤0.01% | 2130 |
|
|
2020
Q3 | $255K | Hold |
4,495
| – | – | ﹤0.01% | 2106 |
|
|
2020
Q2 | $262K | Sell |
4,495
-200
| -4% | -$11.7K | ﹤0.01% | 2028 |
|
|
2020
Q1 | $218K | Hold |
4,695
| – | – | ﹤0.01% | 2046 |
|
|
2019
Q4 | $262K | Buy |
+4,695
| New | +$262K | ﹤0.01% | 2194 |
|